Latest Blogs

Jan 16, 2020
As the world’s leading organization of oncology professionals who care for people with cancer, ASCO believes it is critical to understand what the public, including patients, think of, expect, and need from the nation’s cancer care system.
Jan 14, 2020
Wherever we live, whatever we do for our day jobs, we have a responsibility to be politically aware and politically engaged.
Jan 09, 2020
What had just happened in an examination room that led to that truly intimate moment in the small space of the elevator? 
Jan 08, 2020
The December holidays are always a hard time for my patients, and as a result, for me and my health care team. It’s hard to feel so depleted when there is so much pressure to be festive and merry.
Subscribe to this column

Matthew S. Katz, MD

Matthew S. Katz, MD, is the Medical Director of Radiation Oncology at Lowell General Hospital and a partner in Radiation Oncology Associates, PA. He is former Chair of the Communications Committee for the American Society for Radiation Oncology (ASTRO) and External Advisory Board member for Mayo Clinic Center for Social Media. He serves on ASCO's Social Media Working Group, ASTRO's Education Committee, and Massachusetts Medical Society's Communications Committee. His areas of prime interest are patient education and health empowerment. Follow Dr. Katz on Twitter @subatomicdoc.

Nov 15, 2018
During my career, pathologists have always been the “doctor’s doctor.” Why can't they be the "patient's doctor" as well?
Dec 06, 2017
Only 11% of randomized trials give enough detail to practically use in clinical practice. Here are five ways we can use internet-based communication to make it easier for academic innovators to get credit for their work, and  to implement new findings for our patients.
Jul 12, 2017
Here are 10 reasons why we should look at postoperative radiation for regional melanoma.
Jul 19, 2016
Drug companies play a key role in improving cancer care, but financial toxicity for patients continues to worsen. Eternal vigilance is the price of liberty from excessive drug costs, and we have an ethical obligation to hold pharmaceutical companies accountable.
Apr 08, 2016
We have discussed risk, biology, and the importance of complete reporting. So how do we decide to actually use RNI?
Apr 04, 2016
How we report clinical trials makes interpreting their results harder. Why shouldn’t we all have more information to make better decisions for our patients?

Pages